What is HC Wainwright’s Estimate for BHST Q2 Earnings?

BioHarvest Sciences Inc. (NASDAQ:BHST) – Research analysts at HC Wainwright issued their Q2 2025 earnings per share estimates for shares of BioHarvest Sciences in a research report issued on Tuesday, April 8th. HC Wainwright analyst A. Dayal expects that the company will earn ($0.10) per share for the quarter. HC Wainwright has a “Buy” rating and a $14.00 price objective on the stock. The consensus estimate for BioHarvest Sciences’ current full-year earnings is ($0.80) per share. HC Wainwright also issued estimates for BioHarvest Sciences’ Q3 2025 earnings at ($0.05) EPS and FY2029 earnings at $1.15 EPS.

BioHarvest Sciences (NASDAQ:BHST) last posted its earnings results on Monday, March 31st. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by ($0.05). The firm had revenue of $7.17 million during the quarter, compared to the consensus estimate of $7.24 million.

Separately, Maxim Group assumed coverage on shares of BioHarvest Sciences in a research report on Wednesday, December 18th. They set a “buy” rating and a $12.00 price target on the stock.

BioHarvest Sciences Stock Performance

BHST stock opened at $5.40 on Wednesday. The company has a market cap of $88.70 million, a PE ratio of -4.32 and a beta of 0.84. BioHarvest Sciences has a 1 year low of $5.10 and a 1 year high of $7.38. The business’s 50-day moving average price is $5.72.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in BioHarvest Sciences stock. TD Waterhouse Canada Inc. purchased a new position in shares of BioHarvest Sciences Inc. (NASDAQ:BHST) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 12,042 shares of the company’s stock, valued at approximately $69,000. TD Waterhouse Canada Inc. owned approximately 0.07% of BioHarvest Sciences at the end of the most recent quarter.

About BioHarvest Sciences

BioHarvest Sciences Inc is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications.